From Chronic Pain to Dependence: Why Musculoskeletal Care Must Consider the Whole Patient

Image by kuprevich on Magnific

Chronic musculoskeletal pain is one of the most common reasons people seek medical help, and for many patients, opioid analgesics become part of long-term management. Yet the same medications that ease persistent pain also carry a well-documented risk of dependence. For clinicians working in musculoskeletal medicine, physiotherapy, and rehabilitation, understanding the pathway from chronic pain to problematic substance use is essential, because the two are far more closely linked than they first appear.

How chronic musculoskeletal pain leads to opioid use

Persistent pain from arthritis, back and neck conditions, injuries, and degenerative disease rarely resolves with a single intervention. When conservative measures fall short, opioids are often introduced to provide relief and restore function. In the short term this can be entirely appropriate, but chronic non-cancer pain is a different challenge, and prolonged opioid use raises the odds of tolerance, escalating doses, and physical dependence.

The difficulty is that the transition from legitimate pain relief to dependence is gradual and easy to miss. A patient managing genuine pain may slowly find themselves needing more medication for the same effect, then relying on it to feel normal, without ever intending to misuse anything. Recognising this trajectory early is one of the most valuable things a clinician can do.

When pain care must include rehabilitation

For a subset of patients, opioid use crosses into dependence that pain management alone cannot resolve. At that point, treating the pain without addressing the substance use is unlikely to succeed, and referral to dedicated addiction support becomes an important part of the care pathway. Structured programs, such as rehabilitation Gold Coast services, can provide the medically supervised detox and psychological support that a standard pain clinic is not designed to deliver.

Framing this as part of good musculoskeletal care, rather than a failure of it, matters. Dependence is a recognised clinical outcome of long-term opioid therapy, not a moral shortcoming, and patients are far better served when clinicians can discuss it openly and connect them to appropriate help without judgement.

Recognising the warning signs

Identifying problematic opioid use early gives patients the best chance of a good outcome. Clinicians should stay alert to signs that use may be shifting from therapeutic to problematic, including:

Requesting escalating doses or early prescription renewals.
Reporting that the medication is needed for reasons beyond the original pain.
Distress, anxiety, or preoccupation around running out of medication.
Seeking prescriptions from multiple providers.
Declining function or worsening mood despite continued or increased use.

None of these signs is conclusive on its own, but together they warrant a careful, compassionate conversation about the patient’s relationship with their medication. Validated screening tools and shared decision-making can make these discussions less confronting and more productive for both clinician and patient.

The scale of the issue in Australia

The numbers underline how widespread the problem is. According to Painaustralia, around one in five Australians aged 45 and over live with chronic pain, and people with chronic pain are almost three times as likely to be dispensed opioids as those without it. With millions affected, even a small proportion developing dependence represents a significant clinical and public health burden.

That burden is not evenly shared. Rural and remote Australians tend to face higher rates of prescription and poorer access to comprehensive pain management, and chronic pain frequently travels alongside mental health conditions, which further complicates treatment. The picture that emerges is of a large population managing pain in ways that carry real, ongoing risk.

Managing pain without fuelling dependence

Prevention remains the strongest tool, and modern pain care increasingly emphasises approaches that reduce reliance on opioids.

A multimodal approach

Combining physical therapy, exercise, psychological support, and non-opioid medications can manage pain effectively while lowering the risks tied to long-term opioid use. This whole-person model treats pain as the complex, multifactorial experience it is, rather than a problem to be solved with a single prescription.

Careful prescribing and review

Where opioids are used, starting low, reviewing regularly, using the smallest effective supply, and planning for tapering all help reduce the risk of dependence taking hold. Clear communication with patients about these risks from the outset sets realistic expectations and builds trust. Documenting goals of therapy, agreeing on how progress will be measured, and revisiting whether opioids are still delivering meaningful benefit all help keep long-term prescribing intentional rather than automatic.

Treating pain and dependence together

The link between chronic musculoskeletal pain and opioid dependence is a reminder that patients cannot be treated in silos. Pain and substance use influence one another, and the most effective care recognises both, connecting patients to pain specialists and, when needed, to addiction and rehabilitation services that work in concert rather than isolation.

For clinicians in musculoskeletal fields, this means looking beyond the immediate complaint to the whole person in front of them. Managing pain well, prescribing thoughtfully, watching for the early signs of dependence, and knowing when to refer are all part of delivering care that genuinely improves lives rather than trading one problem for another. Building relationships with local addiction and rehabilitation services, so that referral pathways are already in place before they are needed, makes that transition far smoother for patients at a vulnerable moment. Treating the whole patient is not just good practice; in this context, it can be lifesaving.